Is Novo Nordisk (NYSE:NVO) Starting To Look Interesting After A 52% One Year Slide? [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Investors may be wondering if Novo Nordisk at around US$38.43 is starting to look interesting again, or if recent weakness is a warning sign for valuation focused investors. The stock has seen a 0.7% decline over the last week, a 22.5% decline over the last month, a 26.6% decline year to date, and a 51.6% decline over the past year, with a 45.9% decline over three years and a 20.1% gain over five years. These price moves sit against a backdrop of ongoing attention on Novo Nordisk's role in pharmaceuticals, including scrutiny of its position in weight management and diabetes treatments, and how competition and regulation could affect long term expectations. Investors watching these themes often reassess what they are willing to pay for the stock, which can feed directly into valuation swings. On Simply Wall St's 6 point valuation framework, Novo Nordisk scores a 5 out of 6 . This raises important questions about how different methods like discounted cash flow, P/E comparisons an
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India [Yahoo! Finance]Yahoo! Finance
- Ozempic Is About to Go Generic in India, China and Canada [The New York Times]The New York Times
- Novo Nordisk Obesity Drug Data Sparks Questions On Valuation And Momentum [Yahoo! Finance]Yahoo! Finance
- Analysis-TrumpRx lists many medicines at prices higher than paid in UK [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says [CNBC]CNBC
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/17/26 - Form 6-K
- 3/9/26 - Form 6-K
- 3/2/26 - Form 6-K
- NVO's page on the SEC website